1 475 patientsOf the 4,116 children treated, 1,475 were treated with dihydroartemisinin-piperaquine.
Gabonpaludismepublié 2011PLoS medicineeurope_pmcdocument de 15 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 030 evidences · page 26 / 42
1 475 patientsOf the 4,116 children treated, 1,475 were treated with dihydroartemisinin-piperaquine.
Gabonpaludismepublié 2011PLoS medicineeurope_pmcdocument de 15 observations
74,3 %Three members of the Anopheles gambiae sensu lato complex were collected: Anopheles gambiae sensu stricto (74.3%), Anopheles coluzzii (22.9%), and Anopheles arabiensis (2.8%).
Gabonpaludismeobservé June to September 2022publié 2024Parasites & vectorseurope_pmcdocument de 12 observations
27 isolatesTwenty-seven Plasmodium falciparum isolates were collected from patients with uncomplicated malaria (n = 25) or severe malaria (n = 2).
Gabonpaludismepublié 2017BMC Infectious DiseasesOpenAlexdocument de 12 observationsDOI 10.1186/s12879-017-2552-0
80 %In 2019, the wild-type pfmdr1 haplotype NEYND was observed in 80% of the study population in Libreville, Gabon.
Gabonpaludismeobservé 2019publié 2026Acta tropicaPubMeddocument de 13 observations
50 %50% of malaria infections were reported in children aged 10–17 years.
Gabonpaludismeobservé October 2020 to January 2021publié 2023Tropical medicine and infectious diseaseeurope_pmcdocument de 10 observations
70,7 %The wild-type N86 Pfmdr1 genotype prevalence in asymptomatic infections was 70.7%.
Gabonpaludismepublié 2021Infection and drug resistanceeurope_pmcdocument de 10 observationsDOI 10.2147/idr.s304361
92 %Of 106 Plasmodium falciparum isolates from Lambaréné, 98 (92%) carried the triple mutant dhfr haplotype.
Gabonpaludismepublié 2011Malaria journaleurope_pmcdocument de 5 observationsDOI 10.1186/1475-2875-10-123
46,6 %The NFD haplotype was present in 46.6% of samples from Lastourville.
Gabonpaludismepublié 2016Malaria journaleurope_pmcdocument de 25 observations
75 %Uncorrected adequate clinical and parasitological response (ACPR) in the intention-to-treat set was 75% for artesunate-pyronaridine-atovaquone-proguanil (APAP) at day 42.
Gabonpaludismepublié 2026The Lancet. Microbeeurope_pmcdocument de 21 observations
17,8 %Plasmodium malariae accounted for 17.8% of Plasmodium species identified in malaria cases in Franceville between 2017 and 2019.
Gabonpaludismeobservé 2017-2019publié 2023Journal of public health in Africaeurope_pmcdocument de 7 observationsDOI 10.4081/jphia.2023.1865
24 %The prevalence of Plasmodium falciparum asymptomatic infection among pregnant women was 24% as detected by microscopy.
Gabonpaludismepublié 2012Journal of biomedicine & biotechnologyeurope_pmcdocument de 4 observationsDOI 10.1155/2012/198317
-0,02 correlation_coefficientAnti-CSP IgG responses to primary vaccination did not correlate with a baseline signature of previous exposure in children (Pearson's r = -0·02 [95% CI -0·13 to 0·10]).
Gabonpaludismepublié 2025The Lancet. Infectious diseasesPubMeddocument de 11 observations
49 %Severe anemia was observed in 49.0% of severe malaria cases.
Gabonpaludismeobservé 2019publié 2023BMC Infectious DiseasesOpenAlexdocument de 14 observationsDOI 10.1186/s12879-023-08133-y
6,1 %Coma occurred in 6.1% of severe malaria cases among children living in urban areas in southeastern Gabon in 2019.
Gabonpaludismeobservé 2019publié 2023BMC infectious diseaseseurope_pmcdocument de 14 observations
273 schoolchildrenBlood samples were collected from 273 schoolchildren, of whom 120 were infected with Plasmodium falciparum and 153 were uninfected.
Gabonpaludismepublié 2021Clinical and experimental immunologyeurope_pmcdocument de 4 observationsDOI 10.1111/cei.13653
72 %In 72.0% of malaria-confirmed infants under three months old at the Libreville Mother and Child University Hospital from 2020 to 2024, the blood smear became negative after the ninth dose of antimalarial treatment.
Gabonpaludismeobservé 2020 to 2024publié 2026Journal of African NeonatologyOpenAlexdocument de 15 observationsDOI 10.4314/jan.v4i2.6
0,03 p-valueCotrimoxazole chemoprophylaxis was associated with a reduction in Plasmodium falciparum parasitemia (p = 0.03).
Gabonpaludismeobservé 2021 to 2022publié 2026PloS onePubMeddocument de 11 observations
89 %The per-protocol, PCR-adjusted day 28 cure rate was 89% (42/47) in a study of fosmidomycin plus clindamycin for uncomplicated Plasmodium falciparum malaria in pediatric outpatients aged 1 to 14 years.
Gabonpaludismepublié 2006Antimicrobial agents and chemotherapyeurope_pmcdocument de 8 observations
96 per_551.8_person_years_at_riskClinical malaria incidence was 96 per 551.8 person-years at risk in the sulfadoxine-pyrimethamine group and 130 per 1,103.2 person-years at risk in the mefloquine group.
Gabonpaludismepublié 2014PLoS medicineeurope_pmcdocument de 9 observations
3,3 %Plasmodium malariae prevalence was 3.3% (4/122) among malaria-positive patients.
Gabonpaludismeobservé 2016publié 2021Journal of global antimicrobial resistanceeurope_pmcdocument de 12 observations
1,1 µg/mLItraconazole shows a median EC(50) value of 1.1 µg/mL against field isolates of Plasmodium falciparum from Lambaréné, Gabon.
Gabonpaludismepublié 2011Wiener klinische Wochenschrifteurope_pmcdocument de 4 observations
1 transferOne transfer of Plasmodium from chimpanzees to gorillas was detected in captive non-human primates living in Gabon.
Gabonpaludismepublié 2016International journal for parasitologyeurope_pmcdocument de 5 observations
52,1 %La prévalence des parasites du paludisme à forme asexuée chez les enfants positifs pour Plasmodium spp. était de 52,1 % dans le groupe APOE Ɛ4 (89 sur 171).
GabonpaludismeHAL · Unilimdocument de 81 observations
40 %The overall prevalence of malaria was 40% among 2381 children in Gabon.
Gabonpaludismepublié 2024Acta parasitologicaeurope_pmcdocument de 4 observationsDOI 10.1007/s11686-023-00783-x
13,5 %During pregnancy, the median prevalence of submicroscopic malaria was 13.5% across 66 substudies.
Gabonpaludismepublié 2023The Lancet. Global healtheurope_pmcdocument de 8 observationsDOI 10.1016/s2214-109x(23)00194-8
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.